ICU overprescribing of Antibiotics for CAP Still a Problem
Antibiotics overprescribing for patients with community-acquired pneumonia is a persisting and significant problem in the ICU, researchers reported at IDWeek 2016.
IDWEEK 2016
Questions Remain About Possible Narcolepsy Risk for Some H1N1 Vaccines
A multinational retrospective analysis failed to confirm a possible association between pediatric narcolepsy and the AS03- and MF-59-adjuvanted monovalent pandemic H1N1 vaccines.
CAPTURE: High Success Rates for Ceftaroline Fosamil for Gram-Positive Bacteremia
Ceftaroline fosamil is associated with improved clinical success rates in patients with gram-positive bacteremia, including MRSA and MSSA.
PPIs and Gastroenteritis Hospitalization: What’s the Risk?
Use of proton pump inhibitors (PPIs) was tied to a higher risk of infectious gastroenteritis hospitalization with increasing risk among increasing doses.
Daptomycin as Effective as Standard of Care in Children with Bacteremia
Daptomycin was as effective as standard of care in treating Staphylococcus aureus bacteremia in children 1-17 years of age, according to study results reported at IDWeek 2016.
Mortality Impact of Antiplatelets on Hospitalized Patients With CAP
Antiplatelet drugs are associated with a reduced risk of mortality among hospitalized patients with community-acquired pneumonia.
Traditional vs. Extended Cefepime Infusion in Critically Ill Patients
Patients with Pseudomonas aeruginosa bacteremia or pneumonia had a reduced 28-day all-cause mortality and length of stay in the intensive care unit (ICU) when administered an extended infusion of cefepime.
MnB Vaccine Induces Immunogenicity Among Young People
The meningococcal Serogroup B vaccine MenB-FHbp (Bivalent rLP2086) induces immunogenicity in young people age 10 to 18.
Similar Safety for Simultaneous and Sequential QIV, PPV in Elderly
Safety profiles for elderly people are similar for simultaneous and sequential administration of quadrivalent influenza vaccine (QIV) and 23-valent pneumococcal polysaccharide vaccine (PPV).
Candidate Shingles Vaccine Shows Promise in Older Adults
Different dosing schedules for a two-dose candidate herpes zoster (HZ) subunit vaccine (HZ/su) exhibited similar immunogenicity and safety profiles among older adults, authors of a randomized, open-label, multicenter phase 3 study reported at IDWeek 2016.
Want to read more?
Please login or register first to view this content.
